CAD 0.07
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 48.7 Million CAD | 1.93% |
2022 | 47.78 Million CAD | 28.74% |
2021 | 37.11 Million CAD | 226.7% |
2020 | 11.36 Million CAD | 92.53% |
2019 | 5.9 Million CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | 0.0% |
2006 | - CAD | 0.0% |
2005 | - CAD | 0.0% |
2004 | - CAD | 0.0% |
2003 | - CAD | 0.0% |
2002 | - CAD | 0.0% |
2001 | - CAD | 0.0% |
2000 | - CAD | 0.0% |
1999 | - CAD | 0.0% |
1998 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 47.6 Million CAD | -7.65% |
2024 Q1 | 51.54 Million CAD | 1.88% |
2023 Q3 | 48.42 Million CAD | 9.52% |
2023 FY | 50.59 Million CAD | 5.89% |
2023 Q2 | 44.21 Million CAD | -8.87% |
2023 Q1 | 48.51 Million CAD | 1.54% |
2023 Q4 | 50.59 Million CAD | 4.48% |
2022 Q4 | 47.78 Million CAD | -1.06% |
2022 Q1 | 38.97 Million CAD | 5.0% |
2022 Q2 | 38.03 Million CAD | -2.41% |
2022 FY | 47.78 Million CAD | 28.74% |
2022 Q3 | 48.29 Million CAD | 26.99% |
2021 Q2 | 22.14 Million CAD | 34.95% |
2021 Q1 | 16.4 Million CAD | 44.42% |
2021 FY | 37.11 Million CAD | 226.7% |
2021 Q4 | 37.11 Million CAD | 35.13% |
2021 Q3 | 27.46 Million CAD | 24.05% |
2020 Q1 | 7.93 Million CAD | 34.52% |
2020 Q4 | 11.36 Million CAD | 25.72% |
2020 Q3 | 9.03 Million CAD | 4.4% |
2020 FY | 11.36 Million CAD | 92.53% |
2020 Q2 | 8.65 Million CAD | 9.05% |
2019 Q2 | 952 Thousand CAD | 18.26% |
2019 Q1 | 805 Thousand CAD | 0.0% |
2019 FY | 5.9 Million CAD | 0.0% |
2019 Q4 | 5.9 Million CAD | 679.52% |
2019 Q3 | 757 Thousand CAD | -20.48% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q2 | - CAD | -100.0% |
2010 Q1 | 3692.00 CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q4 | - CAD | -100.0% |
2009 Q1 | - CAD | 0.0% |
2009 Q3 | 18.11 Thousand CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2007 Q1 | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
2007 Q3 | - CAD | 0.0% |
2007 Q2 | - CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2006 Q2 | - CAD | 0.0% |
2006 Q3 | - CAD | 0.0% |
2006 Q1 | - CAD | 0.0% |
2006 Q4 | - CAD | 0.0% |
2006 FY | - CAD | 0.0% |
2005 Q3 | - CAD | 0.0% |
2005 Q2 | - CAD | 0.0% |
2005 FY | - CAD | 0.0% |
2005 Q4 | - CAD | 0.0% |
2005 Q1 | - CAD | 0.0% |
2004 Q1 | - CAD | 0.0% |
2004 Q2 | - CAD | 0.0% |
2004 Q4 | - CAD | 0.0% |
2004 FY | - CAD | 0.0% |
2004 Q3 | - CAD | 0.0% |
2003 FY | - CAD | 0.0% |
2003 Q4 | - CAD | -100.0% |
2003 Q3 | 1078.00 CAD | 0.0% |
2003 Q2 | - CAD | 0.0% |
2003 Q1 | - CAD | 0.0% |
2002 Q4 | - CAD | 0.0% |
2002 Q3 | - CAD | 0.0% |
2002 Q2 | - CAD | 0.0% |
2002 FY | - CAD | 0.0% |
2002 Q1 | - CAD | 0.0% |
2001 Q1 | - CAD | 0.0% |
2001 FY | - CAD | 0.0% |
2001 Q4 | - CAD | 0.0% |
2001 Q3 | - CAD | 0.0% |
2001 Q2 | - CAD | 0.0% |
2000 Q2 | - CAD | 0.0% |
2000 FY | - CAD | 0.0% |
2000 Q3 | - CAD | 0.0% |
1999 Q3 | - CAD | 0.0% |
1999 FY | - CAD | 0.0% |
1998 FY | - CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 123.74 Thousand CAD | -39258.848% |
CanadaBis Capital Inc. | 5.82 Million CAD | -735.697% |
Delivra Health Brands Inc. | 1.47 Million CAD | -3195.332% |
Entourage Health Corp. | 10.01 Million CAD | -386.545% |
Lifeist Wellness Inc. | 4.51 Million CAD | -979.655% |
Cannara Biotech Inc. | 33.77 Million CAD | -44.218% |
Medicure Inc. | 2.9 Million CAD | -1579.483% |
PharmaCielo Ltd. | 2.31 Million CAD | -2007.411% |
Rubicon Organics Inc. | 11.27 Million CAD | -331.82% |
BioSyent Inc. | 5.89 Million CAD | -726.279% |
Voyageur Pharmaceuticals Ltd. | 10.32 Thousand CAD | -471710.52% |